ISPOR Europe 2023

ISPOR EUROPE 2023 – 12-15 NOVEMBER, COPENHAGEN, DENMARK

Join EVERSANA and global healthcare leaders as they convene at ISPOR Europe 2023, the leading global conference for Health Economics and Outcomes Research (HEOR).

Our Value & Evidence , Data & Analytics 和 NAVLIN’s HTA, Pricing & Access experts will be onsite to discuss how we use a variety of analytics, evidence generation, and evidence synthesis activities to help support market access and reimbursement for pharmaceutical and medical devices.

Schedule a meeting with one of our experts to discuss your business needs and visit us in Booth #C3-060.

Don’t Miss this Featured Spotlight Session

Spotlight Session 132: Monday, 13 November 13:45-14:45

Navigating Challenges and Seizing Opportunities: Leveraging Multiple RWD Sources in External Control Arms for HTA and Regulatory Decision Making

This panel aims to explore how leveraging and harmonizing multiple RWD sources can enhance the evidentiary requirements of global HTA and regulatory bodies. Moderated by Dr. Chris Cameron, the panel will provide an overview of HTA/regulatory guidance documents on RWD/RWE sources and summarize recent ECA submission review results.

MODERATOR: Chris Cameron, MSc, PhD, EVERSANA

PANELISTS

Nicolle Gatto, PhD, Aetion, New York, NY, USA
Qiufei Ma, PhD, Regeneron Pharmaceuticals, Inc, Oak Park, CA, USA
Uwe Siebert, MD, MPH, MSc, ScD, UMIT TIROL – University for Health Sciences and Technology, Hall in Tirol, Austria. ONCOTYROL – Center for Personalized Cancer Medicine, Innsbruck, Austria. Harvard T.H. Chan School of Public Health and Harvard Medical School, Boston, MA, USA

EVERSANA’s 2023 Poster Presentations

We are proud to present several posters at this year’s ISPOR conference. Check the links below for more details on each abstract. If you are attending in person, download the schedule.